Loading…
Based on limited metadata, Akan Biosciences, Inc. received an FDA Warning Letter on April 30, 2024, regarding biologics products. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's biologics regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the detailed compliance concerns and required corrective actions, the complete warning letter would need to be reviewed.